{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:03:45Z","timestamp":1778825025344,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,8,27]],"date-time":"2008-08-27T00:00:00Z","timestamp":1219795200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1038\/npp.2008.138","type":"journal-article","created":{"date-parts":[[2008,8,27]],"date-time":"2008-08-27T14:15:52Z","timestamp":1219846552000},"page":"759-766","source":"Crossref","is-referenced-by-count":326,"title":["\u03949-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum"],"prefix":"10.1038","volume":"34","author":[{"given":"Matthijs G","family":"Bossong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart NM","family":"van Berckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Boellaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lineke","family":"Zuurman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C","family":"Schuit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert D","family":"Windhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joop M A","family":"van Gerven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick F","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriaan A","family":"Lammertsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9 S","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,27]]},"reference":[{"key":"BFnpp2008138_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0166-2236(84)80062-4","volume":"7","author":"B Angrist","year":"1984","unstructured":"Angrist B, Van Kammen DP (1984). CNS stimulants as tools in the study of schizophrenia. Trends Neurosci 7: 388\u2013390.","journal-title":"Trends Neurosci"},{"key":"BFnpp2008138_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1192\/bjp.184.2.110","volume":"184","author":"L Arseneault","year":"2004","unstructured":"Arseneault L, Cannon M, Witton J, Murray RM (2004). Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184: 110\u2013117.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2008138_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/syn.10226","volume":"49","author":"I Boileau","year":"2003","unstructured":"Boileau I, Assaad JM, Pihl RO, Benkelfat C, Leyton M, Diksic M et al (2003). Alcohol promotes dopamine release in the human nucleus accumbens. Synapse 49: 226\u2013231.","journal-title":"Synapse"},{"key":"BFnpp2008138_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.2044-8341.1974.tb02285.x","volume":"47","author":"A Bond","year":"1974","unstructured":"Bond A, Lader M (1974). The use of analogue scales in rating subjective feelings. Br J Med Psychol 47: 211\u2013218.","journal-title":"Br J Med Psychol"},{"key":"BFnpp2008138_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/00000542-199801000-00015","volume":"88","author":"TA Bowdle","year":"1998","unstructured":"Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy-Byrne PP (1998). Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology 88: 82\u201388.","journal-title":"Anesthesiology"},{"key":"BFnpp2008138_CR6","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","volume":"94","author":"A Breier","year":"1997","unstructured":"Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, De Bartolomeis A et al (1997). Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 94: 2569\u20132574.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2008138_CR7","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1001\/archpsyc.63.7.808","volume":"63","author":"AL Brody","year":"2006","unstructured":"Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S et al (2006). Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate\/nucleus accumbens. Arch Gen Psychiatry 63: 808\u2013816.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2008138_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1176\/appi.ajp.161.7.1211","volume":"161","author":"AL Brody","year":"2004","unstructured":"Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P et al (2004). Smoking-induced ventral striatum dopamine release. Am J Psychiatry 161: 1211\u20131218.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2008138_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/syn.10282","volume":"51","author":"L Cardenas","year":"2004","unstructured":"Cardenas L, Houle S, Kapur S, Busto UE (2004). Oral D-amphetamine causes prolonged displacement of [11C]raclopride as measured by PET. Synapse 51: 27\u201331.","journal-title":"Synapse"},{"key":"BFnpp2008138_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/00004647-199704000-00009","volume":"17","author":"RE Carson","year":"1997","unstructured":"Carson RE, Breier A, de Bartolomeis A, Saunders RC, Su TP, Schmall B et al (1997). Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. J Cereb Blood Flow Metab 17: 437\u2013447.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2008138_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/BF02245916","volume":"102","author":"JP Chen","year":"1990","unstructured":"Chen JP, Paredes W, Li J, Smith D, Lowinson J, Gardner EL (1990). Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology (Berl) 102: 156\u2013162.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2008138_CR12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.neuroimage.2004.01.016","volume":"22","author":"J Cizek","year":"2004","unstructured":"Cizek J, Herholz K, Vollmar S, Schrader R, Klein J, Heiss WD (2004). Fast and robust registration of PET and MR images of human brain. NeuroImage 22: 434\u2013442.","journal-title":"NeuroImage"},{"key":"BFnpp2008138_CR13","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","volume":"57","author":"DC D\u2019Souza","year":"2005","unstructured":"D\u2019Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G et al (2005). Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry 57: 594\u2013608.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2008138_CR14","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","volume":"29","author":"DC D\u2019Souza","year":"2004","unstructured":"D\u2019Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT et al (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29: 1558\u20131572.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2008138_CR15","volume-title":"SCL-90-R: Administration, Scoring, and Procedures Manual\u2014II","author":"JR Derogatis","year":"1983","unstructured":"Derogatis JR (1983). SCL-90-R: Administration, Scoring, and Procedures Manual\u2014II. Clinical Psychometric Research: Townson."},{"key":"BFnpp2008138_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0006-3223(00)01038-6","volume":"49","author":"WC Drevets","year":"2001","unstructured":"Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA et al (2001). Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49: 81\u201396.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2008138_CR17","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1097\/01.wnr.0000236853.40221.8e","volume":"17","author":"P Fadda","year":"2006","unstructured":"Fadda P, Scherma M, Spano MS, Salis P, Melis V, Fattore L et al (2006). Cannabinoid self-administration increases dopamine release in the nucleus accumbens. Neuroreport 17: 1629\u20131632.","journal-title":"Neuroreport"},{"key":"BFnpp2008138_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0304-3940(97)00278-4","volume":"226","author":"ED French","year":"1997","unstructured":"French ED (1997). Delta9-tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neurosci Lett 226: 159\u2013162.","journal-title":"Neurosci Lett"},{"key":"BFnpp2008138_CR19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00001756-199702100-00014","volume":"8","author":"ED French","year":"1997","unstructured":"French ED, Dillon K, Wu X (1997). Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport 8: 649\u2013652.","journal-title":"Neuroreport"},{"key":"BFnpp2008138_CR20","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1021\/ja01062a046","volume":"86","author":"Y Gaoni","year":"1964","unstructured":"Gaoni Y, Mechoulam R (1964). Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 86: 1646\u20131647.","journal-title":"J Am Chem Soc"},{"key":"BFnpp2008138_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.pbb.2005.01.032","volume":"81","author":"EL Gardner","year":"2005","unstructured":"Gardner EL (2005). Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol Biochem Behav 81: 263\u2013284.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2008138_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0014-2999(97)01442-8","volume":"341","author":"GL Gessa","year":"1998","unstructured":"Gessa GL, Melis M, Muntoni AL, Diana M (1998). Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur J Pharmacol 341: 39\u201344.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2008138_CR23","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1126\/science.277.5327.749a","volume":"277","author":"L Grinspoon","year":"1997","unstructured":"Grinspoon L, Bakalar JB, Zimmer L, Morgan JP (1997). Marijuana addiction. Science 277: 749.","journal-title":"Science"},{"key":"BFnpp2008138_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1371\/journal.pmed.0030039","volume":"3","author":"W Hall","year":"2006","unstructured":"Hall W (2006). The mental health risks of adolescent cannabis use. PLoS Med 3: 159\u2013162.","journal-title":"PLoS Med"},{"key":"BFnpp2008138_CR25","first-page":"48","volume":"11","author":"JL Hedlund","year":"1980","unstructured":"Hedlund JL, Vieweg BW (1980). The Brief Psychiatric Rating Scale (BPRS): a comprehensive review. J Oper Psychiatry 11: 48\u201365.","journal-title":"J Oper Psychiatry"},{"key":"BFnpp2008138_CR26","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/jat\/16.5.276","volume":"16","author":"MA Huestis","year":"1992","unstructured":"Huestis MA, Henningfield JE, Cone EJ (1992). Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol 16: 276\u2013282.","journal-title":"J Anal Toxicol"},{"key":"BFnpp2008138_CR27","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1001\/archpsyc.58.12.1118","volume":"58","author":"HE Hulshoff Pol","year":"2001","unstructured":"Hulshoff Pol HE, Schnack HG, Mandl RC, van Haren NE, Koning H, Collins DL et al (2001). Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry 58: 1118\u20131125.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2008138_CR28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.neuro.29.051605.113009","volume":"29","author":"SE Hyman","year":"2006","unstructured":"Hyman SE, Malenka RC, Nestler EJ (2006). Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29: 565\u2013598.","journal-title":"Annu Rev Neurosci"},{"key":"BFnpp2008138_CR29","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/00008877-200509000-00023","volume":"16","author":"AB Ilan","year":"2005","unstructured":"Ilan AB, Gevins A, Coleman M, ElSohly MA, De Wit H (2005). Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids. Behav Pharmacol 16: 487\u2013496.","journal-title":"Behav Pharmacol"},{"key":"BFnpp2008138_CR30","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN et al (2007). Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27: 1533\u20131539.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2008138_CR31","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0896-6273(00)80557-7","volume":"21","author":"GF Koob","year":"1998","unstructured":"Koob GF, Sanna PP, Bloom FE (1998). Neuroscience of addiction. Neuron 21: 467\u2013476.","journal-title":"Neuron"},{"key":"BFnpp2008138_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/00004647-199601000-00005","volume":"16","author":"AA Lammertsma","year":"1996","unstructured":"Lammertsma AA, Bench CJ, Hume SP, Osman S, Gunn K, Brooks DJ et al (1996). Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab 16: 42\u201352.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2008138_CR33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/00004647-200003000-00001","volume":"20","author":"M Laruelle","year":"2000","unstructured":"Laruelle M (2000). Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J. Cereb. Blood Flow Metab 20: 423\u2013451.","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"BFnpp2008138_CR34","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","volume":"93","author":"M Laruelle","year":"1996","unstructured":"Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J et al (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93: 9235\u20139240.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2008138_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1098-2396(199701)25:1<1::AID-SYN1>3.0.CO;2-H","volume":"25","author":"M Laruelle","year":"1997","unstructured":"Laruelle M, Iyer RN, Al-Tikriti MS, Zea-Ponce Y, Malison R, Zoghbi SS et al (1997). Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse 25: 1\u201314.","journal-title":"Synapse"},{"key":"BFnpp2008138_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1001\/archpsyc.1994.03950040017002","volume":"51","author":"DH Linszen","year":"1994","unstructured":"Linszen DH, Dingemans PM, Lenior ME (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 51: 273\u2013279.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2008138_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/sj.bjp.0705931","volume":"143","author":"CR Lupica","year":"2004","unstructured":"Lupica CR, Riegel AC, Hoffman AF (2004). Marijuana and cannabinoid regulation of brain reward circuits. Br J Pharmacol 143: 227\u2013234.","journal-title":"Br J Pharmacol"},{"key":"BFnpp2008138_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.bjp.0702753","volume":"128","author":"DT Malone","year":"1999","unstructured":"Malone DT, Taylor DA (1999). Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats. Br J Pharmacol 128: 21\u201326.","journal-title":"Br J Pharmacol"},{"key":"BFnpp2008138_CR39","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1176\/ajp.2007.164.4.622","volume":"164","author":"D Martinez","year":"2007","unstructured":"Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A et al (2007). Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry 164: 622\u2013629.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2008138_CR40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.WCB.0000048520.34839.1A","volume":"23","author":"D Martinez","year":"2003","unstructured":"Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y et al (2003). Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 23: 285\u2013300.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2008138_CR41","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/00004647-200109000-00002","volume":"21","author":"O Mawlawi","year":"2001","unstructured":"Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR et al (2001). Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 21: 1034\u20131057.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2008138_CR42","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","volume":"370","author":"TH Moore","year":"2007","unstructured":"Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M et al (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370: 319\u2013328.","journal-title":"Lancet"},{"key":"BFnpp2008138_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0006-8993(88)90749-4","volume":"451","author":"JM Ng Cheong Ton","year":"1988","unstructured":"Ng Cheong Ton JM, Gerhardt GA, Friedemann M, Etgen AM, Rose GM, Sharpless NS et al (1988). The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study. Brain Res 451: 59\u201368.","journal-title":"Brain Res"},{"key":"BFnpp2008138_CR44","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR (1962). The Brief Psychiatric Rating Scale. Psychol Rep 10: 799\u2013812.","journal-title":"Psychol Rep"},{"key":"BFnpp2008138_CR45","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1038\/sj.npp.1301068","volume":"31","author":"JG Ramaekers","year":"2006","unstructured":"Ramaekers JG, Kauert G, van Ruitenbeek P, Theunissen EL, Schneider E, Moeller MR (2006). High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology 31: 2296\u20132303.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2008138_CR46","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1176\/ajp.154.9.1209","volume":"154","author":"TE Schlaepfer","year":"1997","unstructured":"Schlaepfer TE, Pearlson GD, Wong DF, Marenco S, Dannals RF (1997). PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects. Am J Psychiatry 154: 1209\u20131213.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2008138_CR47","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0165-6147(00)01805-8","volume":"22","author":"E Schlicker","year":"2001","unstructured":"Schlicker E, Kathmann M (2001). Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 22: 565\u2013572.","journal-title":"Trends Pharmacol Sci"},{"key":"BFnpp2008138_CR48","doi-asserted-by":"publisher","first-page":"S471","DOI":"10.1002\/jlcr.1200","volume":"50","author":"RC Schuit","year":"2007","unstructured":"Schuit RC, Luurtsema G, Greuter HNJM, Hendrikse NH, Windhorst AD, van Berckel BN et al (2007). Intravenous amphetamine administration does not affect metabolism of [11C]raclopride. J Labelled Compd Rad 50: S471.","journal-title":"J Labelled Compd Rad"},{"key":"BFnpp2008138_CR49","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1126\/science.1145194","volume":"188","author":"P Seeman","year":"1975","unstructured":"Seeman P, Lee T (1975). Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 188: 1217\u20131219.","journal-title":"Science"},{"key":"BFnpp2008138_CR50","doi-asserted-by":"crossref","unstructured":"Strougo A, Zuurman L, Roy C, Pinquier JL, van Gerven JM, Cohen AF et al (2008). Modelling of the concentration\u2013effect relationship of THC on central nervous system parameters and heart rate\u2014insight into its mechanisms of action and a tool for clinical research and development of cannabinoids. J Psychopharmacol. 2008 June 26 [E-pub ahead of print].","DOI":"10.1177\/0269881108089870"},{"key":"BFnpp2008138_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00213-003-1485-z","volume":"169","author":"G Tanda","year":"2003","unstructured":"Tanda G, Goldberg SR (2003). Cannabinoids: reward, dependence, and underlying neurochemical mechanisms\u2014a review of recent preclinical data. Psychopharmacology (Berl) 169: 115\u2013134.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2008138_CR52","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","volume":"276","author":"G Tanda","year":"1997","unstructured":"Tanda G, Pontieri FE, Di Chiara G (1997). Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276: 2048\u20132050.","journal-title":"Science"},{"key":"BFnpp2008138_CR53","first-page":"169","volume":"45","author":"AP van der Weerdt","year":"2004","unstructured":"van der Weerdt AP, Boellaard R, Knaapen P, Visser CA, Lammertsma AA, Visser FC (2004). Postinjection transmission scanning in myocardial 18F-FDG PET studies using both filtered backprojection and iterative reconstruction. J Nucl Med 45: 169\u2013175.","journal-title":"J Nucl Med"},{"key":"BFnpp2008138_CR54","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrn1406","volume":"5","author":"RA Wise","year":"2004","unstructured":"Wise RA (2004). Dopamine, learning and motivation. Nat Rev Neurosci 5: 483\u2013494.","journal-title":"Nat Rev Neurosci"},{"key":"BFnpp2008138_CR55","doi-asserted-by":"crossref","unstructured":"Zuurman L, Roy C, Schoemaker RC, Hazekamp A, Den Hartigh J, Bender JC et al (2008). Effect of intrapulmonary THC administration in humans. J Psychopharmacol. 2008 May 30 [E-pub ahead of print].","DOI":"10.1177\/0269881108089581"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2008138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2008138","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2008138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:17:20Z","timestamp":1684455440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2008138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,27]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["BFnpp2008138"],"URL":"https:\/\/doi.org\/10.1038\/npp.2008.138","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,27]]}}}